NCT01589432View on ClinicalTrials.gov

A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Diabetic Neuropathic Pain
Interventions
DRUG

ABT-639

two 50 mg oral capsules

DRUG

Placebo

2 placebo capsules

DRUG

Lidocaine

3mg/kg infusion over 30 minutes

Trial Locations (1)

SE1 3XF

Site Reference ID/Investigator# 68882, London

All Listed Sponsors
lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01589432 - A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy | Biotech Hunter | Biotech Hunter